News and Announcements
Proteomics Annual Report to Shareholders 2016
- Published August 30, 2016 10:07AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
26th August 2016, ASX Announcement
Window On The Science – Proteins in medicine
A revolution in medicine is well underway, underpinned by the desire for a deeper understanding of the basis of disease beyond that of classical pathology. Determining what is happening at the molecular level can guide treatment of diseases with precision. At its core, this is about proteins. The value of proteomics technology has made it a cornerstone tool to help understand the dynamics of disease in the ever-changing environment that is the living body.
Proteins are giant, complex biological molecules that carry out all the functions within living systems. They have precise modes of action in the human body. Protein drugs, termed biopharmaceuticals, can provide highly complex functions that simple chemicals cannot perform and moreover, are less likely to cause adverse effects.
To view the full announcement, please click on the button below.